Mitsuharu Ueda

← Back to Kumamoto University

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

1. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

   2018 · 3,033 citations

2. JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis

   2020 · 242 citations

3. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations*

   2019 · 199 citations

4. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.

   2000 · 165 citations

5. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study

   2011 · 164 citations

6. Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma

   2009 · 163 citations

7. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy

   2012 · 163 citations

8. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis

   2014 · 161 citations

9. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons

   2011 · 160 citations

10. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

    2020 · 159 citations

11. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

    2018 · 152 citations

12. Recent advances in transthyretin amyloidosis therapy

    2014 · 146 citations

13. Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis

    2022 · 139 citations

14. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis

    2013 · 138 citations

15. Portal Vein Complications in Pediatric Living Donor Liver Transplantation Using Left-Side Grafts

    2008 · 125 citations

16. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information.

    1996 · 123 citations

17. World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

    2023 · 110 citations

18. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy

    2009 · 108 citations

19. Myocardial Late Iodine Enhancement and Extracellular Volume Quantification with Dual-Layer Spectral Detector Dual-Energy Cardiac CT

    2019 · 106 citations

20. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus

    1999 · 103 citations

21. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation

    2004 · 98 citations

22. Portal Vein Complications in the Long-Term Course After Pediatric Living Donor Liver Transplantation

    2005 · 91 citations

23. Diagnostic Utility of Cardiac Troponin T Level in Patients with Cardiac Amyloidosis

    2017 · 88 citations

24. Identification of CXCL5/ENA‐78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer‐associated fibroblasts

    2012 · 84 citations

25. Isolation and Measurement of Pancreatic Amylase in Human Serum and Urine

    1972 · 84 citations

← Return to the university profile